Rtw Investments, LP Uro Gen Pharma Ltd. Transaction History
Rtw Investments, LP
- $5.99 Billion
- Q2 2024
A detailed history of Rtw Investments, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Rtw Investments, LP holds 3,557,347 shares of URGN stock, worth $43.5 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
3,557,347
Previous 3,257,347
9.21%
Holding current value
$43.5 Million
Previous $48.9 Million
22.17%
% of portfolio
1.0%
Previous 0.78%
Shares
4 transactions
Others Institutions Holding URGN
# of Institutions
121Shares Held
39.6MCall Options Held
158KPut Options Held
161K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.3MShares$40.4 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.08MShares$37.7 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.91MShares$35.6 Million12.93% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.45MShares$30 Million0.11% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$28.2 Million0.27% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $278M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...